Phospho-Tau 217, Plasma
Synonyms |
|
||||||||||||
Cerner Name |
|||||||||||||
Clinical Info |
This test is used to aid in the biological identification of Alzheimer's disease by measuring phosphorylated tau 217, which has been shown in the literature to be a surrogate of amyloid pathology. Additionally, pTau-217 can be used for monitoring patients on newly approved anti-amyloid therapy. |
||||||||||||
Specimen Sources |
Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous |
||||||||||||
Specimen Types |
Blood |
||||||||||||
Specimen Volume |
1.0 mL Plasma ( Min 0.75 mL) (Note: This volume does not allow for repeat testing.) |
||||||||||||
Container |
Plasma from a Lavender Top Tube |
||||||||||||
Collection Instructions |
Container /Tube: Lavender Top Tube |
||||||||||||
Transport Instructions |
FROZEN |
||||||||||||
Specimen Stability |
14 Days Frozen |
||||||||||||
Methodology |
Fujirebio Lumipulse chemiluminescent enzyme immunoassay (CLEIA) |
||||||||||||
Days Performed |
TAT: 6-8 Days |
||||||||||||
Performing Laboratories |
Labcorp |
||||||||||||
CPT |
84393 |
||||||||||||
PDM |
245383 |
||||||||||||
Results |
|
||||||||||||
Result Interpretation |
|||||||||||||
Forms |
|
||||||||||||